DB DIAGNOSTICS
- Company typePrivate
- Founded2020
- HeadquartersCharlotte, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
DB DIAGNOSTICS firmographics
Firmographics- Name
- DB DIAGNOSTICS
- Legal name
- DB DIAGNOSTICS LLC
- Website
- https://dbdiagnostics.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
DB DIAGNOSTICS industry classification
Industry- Product category
- Diagnostic Supplies Distribution
- NAICS
- Medical Laboratories (621511)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Point-of-Care & Rapid Diagnostic Testing Centers (non-lab, non-imaging) (HLAFAKAO)
- akta.pro secondary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
Keywords
Where DB DIAGNOSTICS is headquartered
LocationHeadquarters
- HQ city
- Charlotte
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
DB DIAGNOSTICS business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Test Sales: One-time product sales of rapid diagnostic tests including COVID-19 antigen tests, flu tests, strep tests, RSV tests, drug testing kits, blood tests, and pregnancy tests. Products are sold in various pack sizes (2-pack, 25-box, etc.) with minimum order quantities.
- Pharmaceutical Supplies: Sale of pharmaceutical products including Naloxone HCl 4mg Nasal Spray for emergency opioid overdose treatment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Drug Testing Panels - Single Panel |
| Unit Pricing | Pay-as-you-go | Drug Testing Panels - Multi-Panel (5-14 Panel) |
| Unit Pricing | Pay-as-you-go | COVID-19 Antigen Tests |
| Unit Pricing | Pay-as-you-go | Multiplex Respiratory Combo Tests |
| Unit Pricing | Pay-as-you-go | Naloxone HCl 4mg Nasal Spray |
| Unit Pricing | Pay-as-you-go | Blood Testing Products |
| Other | Pay-as-you-go | Bulk/Enterprise Orders |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
DB DIAGNOSTICS product offering
Product offeringCore offering
DB Diagnostics is a wholesale distributor of rapid point-of-care diagnostic tests and select pharmaceutical products for healthcare facilities. Its portfolio spans COVID-19, influenza A/B, RSV, Strep A, mononucleosis, multi-panel drug, pregnancy, and blood (A1c, cholesterol, lipid, glucose) tests, alongside Naloxone HCl nasal spray. The company serves pharmacies, hospitals, urgent cares, complex laboratories, senior housing, government entities, and businesses through an NABP-accredited, CLIA-certified distribution operation with an online ordering portal.
Product overview
DB Diagnostics is a diagnostic and pharmaceutical supplies distributor offering specialized procurement solutions for healthcare settings including hospitals, pharmacies, laboratories, and urgent cares. The company operates as a wholesale distributor rather than a software platform, providing physical diagnostic products rather than an integrated software platform. The product portfolio includes COVID-19 antigen rapid tests (iHealth, Flowflex, Genbody, CareStart, Advin, Indicaid), combination respiratory tests for COVID/Flu/RSV (CorDx TyFast, LifeSign, ViraDx, WELLlife, Healgen), standalone Strep A tests, RSV tests (QuickVue, Nano-Check), Mononucleosis tests (Lifesign Status Mono, AimStep), blood testing products (A1c Now, CardioChek), drug testing panels (1-14 panel dip cards and T-Cups), pregnancy tests, and pharmaceutical products (Naloxone). The company also distributes related supplies like exam gloves. Products are primarily distributed to healthcare facilities, pharmacies, and clinics under CLIA waiver protocols.
Differentiator
Problem solved
Functional benefit
Products and services
- iHealth COVID-19 Antigen Rapid Tests (2-pack) FDA-authorized 15-minute self-test for qualitative detection of SARS-CoV-2 nucleocapsid protein antigen via a non-invasive nasal swab. Intended for ages 2 and above (adult-collection required for ages 2-14). Sold as 2 tests per kit, 90 kits per box.
- iHealth RSV/Flu A&B/COVID-19 4-in-1 Rapid Test (OTC) Over-the-counter 4-in-1 rapid test that detects RSV, Influenza A, Influenza B, and COVID-19 in a single test.
- Genbody COVID-19 Ag (25/box) Rapid qualitative immunochromatographic assay for detection of SARS-CoV-2 antigens in nasopharyngeal or anterior nasal swab specimens, with 92.31% sensitivity and 99.04% specificity. Results in 15-20 minutes for CLIA-certified settings.
- Flowflex (OTC) At-Home COVID Antigen Test Rapid test for detection of SARS-CoV-2 antigens in anterior nasal specimens for self-testing under Emergency Use Authorization, with 15-minute results. For individuals aged 14+ (self-collected) or ages 2+ (adult-collected). NDC: 82607-0660-26.
- Flowflex Plus COVID-19/Flu A&B OTC Rapid Test (2-pack) 3-in-1 home rapid test for COVID-19, Flu A, and Flu B using a nasal swab, with 15-minute results and pediatric use from age 2.
- PreView Strep A Throat Swab Test Kit (25/Box) Qualitative Group A Streptococcal (Strep A) throat swab test kit. CLIA Waived / Professional Use Only, with 10-minute processing time and 95.0% sensitivity.
- CorDx TyFast Flu A/B & COVID-19 Test (At-Home Multiplex Rapid Test) At-home 3-in-1 rapid Flu A/B and COVID-19 test that detects the bird flu strain (Influenza A H5N1) with 10-minute results. 1 test kit per box, 150 test kits per case.
- LifeSign Status COVID/Flu A+B Rapid Antigen Test (25/box) COVID-19/Flu A+B combo rapid antigen test with COVID-19 sensitivity of 93.8% (anterior nasal) and 93.1% (nasopharyngeal), Flu A sensitivity 91.4%, Flu B sensitivity 87.6%. FDA Emergency Use Authorization with 15-minute results.
- LifeSign Status Flu A+B Rapid Test (25/box) Rapid detection of influenza type A and type B from nasal swab, nasopharyngeal swab, and nasal aspirate/wash specimens. CLIA waived for nasal and nasopharyngeal swabs. Detects H1N1 (Swine Flu).
- WELLlife COVID-19/Influenza A&B POC Test Point-of-care test using advanced immunoassay technology to differentiate between SARS-CoV-2, influenza A, and influenza B with a single nasal swab. CLIA WAIVED, 25 tests per box.
- WELLlife Influenza A&B Test (POC) Point-of-care rapid test for qualitative detection of Influenza A and B.
- Healgen Rapid COVID-19/Flu A&B Combo Antigen Test 3-in-1 rapid antigen test detecting COVID-19, Influenza A, and Influenza B with 92.0% sensitivity and 99.0% specificity for COVID-19. Results in 15 minutes. 20 boxes per case.
- Naloxone HCl 4mg Nasal Spray Emergency treatment of opioid overdose. Manufactured by Padagis Pharmaceuticals. Two units per box, 1mL intranasal spray per unit. Special pricing available for EMS, police departments, and non-profit organizations. NDC#: 45802-0578-84.
- Multi-Panel Drug Testing Products (1-14 Panel Dip Cards, T-Cups, T-Cup Compacts) Drug testing panels from single-panel dip cards ($12.50-$18.75) through 14-panel T-Cups ($105.00). Many configurations carry CLIA waiver status. Tests cover AMP, BAR, BUP, BZO, COC, mAMP, MDMA, MTD, OPI, OXY, PCP, TCA, and THC.
- Blood Testing Products (A1c Now, CardioChek Analyzers, Test Strips) Blood testing products including A1c Now Self Check 4-test ($70.95), A1c Now+ 10-test ($125.95) and 20-test ($199.95), A1CNow+ Controls ($154.95), CardioChek PA Analyzer ($749.95), CardioChek Plus Analyzer ($999.95), and test strips for CHOL, HDL, GLU, triglycerides, and lipid panels.
- Pregnancy Tests (hCG Cassette and Strip) hCG-based pregnancy tests in 1-Cassette ($50.00) and 1-Strip ($40.00) formats. CLIA waived. Available in 20, 25, and 50 tests per bag with early detection options.
Companies that use DB DIAGNOSTICS
Customer profileSegments6 records
Ideal customer profiles7 records
DB DIAGNOSTICS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
DB DIAGNOSTICS partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core.
- iHealthcoreiHealth Labs partner providing COVID-19 antigen rapid tests and 4-in-1 RSV/Flu/COVID combination tests. DB Diagnostics distributes iHealth products including iHealth COVID-19 Antigen Rapid Tests (2-pack) at $19.00 and iHealth RSV/Flu A&B/COVID-19 4-in-1 Rapid Test at $34.99.
- HikmacoreHikma Pharmaceuticals logo displayed as partner company providing pharmaceutical products and supplies.
- AmnealcoreAmneal Pharmaceuticals logo displayed as partner company for pharmaceutical product supply.
- Emergent BioSolutionscoreEmergent BioSolutions logo displayed as partner company, likely related to Narcan/Naloxone pharmaceutical products.
- WondfocoreWondfo brand partner providing diagnostic products including alcohol saliva tests. DB Diagnostics sells Wondfo-branded 1-Strip Alcohol Saliva Test at $31.25.
- Visby MedicalcoreVisby Medical logo displayed as partner company in the diagnostics distribution network.
- Lurica LabscoreLurica Labs logo displayed as partner company in the diagnostics distribution network.
- LifeSign (Princeton Biomedical)coreLifeSign Status brand partner providing COVID/Flu A+B combo tests, Flu A+B tests, Mono tests, and Strep-A tests. DB Diagnostics distributes LifeSign products including Status COVID/FLUA+B Rapid Antigen Test at $380.00.
- IntrivocoreIntrivo logo displayed as partner company in the diagnostics and testing products network.
- MedeacoreMedea logo displayed as partner company in the diagnostics distribution network.
- RNScoreRNS logo displayed as partner company in the diagnostics distribution network.
Scale indicators3 records
Expansion highlights5 records
DB DIAGNOSTICS competitors and assessment
Company assessmentBroad incumbents
- McKesson Corporation: Largest U.S. pharmaceutical and medical supply distributor serving pharmacies, hospitals, and labs. Directly comparable as a multi-line wholesale channel competing with DB Diagnostics for healthcare facility and pharmacy business across overlapping product categories.
- Owens & Minor: Medical and surgical supply distributor serving hospitals, laboratories, and senior housing facilities. Comparable as a national wholesale channel competing for institutional customers and senior housing accounts similar to DB Diagnostics' stated segments.
- Medline Industries: Large manufacturer and distributor of medical and surgical supplies serving hospitals, clinics, and senior housing. Comparable as a broad-line supplier to the same healthcare facility and senior housing customer base.
- Cardinal Health: Major U.S. medical product distributor with extensive pharmacy and clinical laboratory supply operations. Comparable as a large-scale wholesale channel for diagnostic tests, pharmaceuticals, and medical supplies to the same end customer segments as DB Diagnostics.
- Henry Schein: Distributor serving physician offices, urgent cares, labs, and pharmacies with diagnostic, pharmaceutical, and medical-surgical supplies. Directly comparable as a B2B distributor competing for similar CLIA-waived POC and OTC test orders.
- Thermo Fisher Scientific: Global life sciences and clinical diagnostics supplier with Fisher Healthcare distribution serving labs, hospitals, and physician offices. Comparable as a scaled channel for diagnostic tests and laboratory supplies to overlapping clinical customers.
Direct peers
- BTNX Inc. Rapid diagnostic test manufacturer and distributor known for drug test cups and lateral flow assays sold into pharmacies, workplaces, and clinics. Comparable as a specialty distributor/manufacturer whose drug-testing and infectious-disease SKUs overlap with DB Diagnostics' drug panel and respiratory test lines.
- QuidelOrtho: Specialized diagnostics company producing rapid point-of-care tests sold through distribution to clinics, urgent cares, and pharmacies. Most directly comparable as a specialty POC/rapid-test manufacturer and distributor occupying overlapping shelf space with DB Diagnostics' COVID/Flu/RSV/Strep/Mono catalog.
Others
- iHealth Labs: Manufacturer of COVID-19, Flu, and RSV OTC rapid tests that is currently a key supplier of DB Diagnostics. Included as a critical upstream partner whose direct-to-consumer and own-channel distribution could overlap with DB Diagnostics' pharmacy and clinic accounts.
Emerging players
- Wondfo USA: U.S. subsidiary of Wondfo, a rapid diagnostic test manufacturer whose products (including alcohol saliva tests) are distributed by DB Diagnostics. Comparable as a competing specialty brand/distributor in the same at-home and POC testing categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
DB DIAGNOSTICS social profiles
Digital presenceDB DIAGNOSTICS compliance and trust
Trust signalCompliance2 records
DB DIAGNOSTICS financial estimates
Financial estimateRevenue estimate
Valuation estimate
DB DIAGNOSTICS leadership team
Management profileNumber of profiles
Profiles1 record
DB DIAGNOSTICS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DB DIAGNOSTICS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DB DIAGNOSTICS
What does DB DIAGNOSTICS do?
DB Diagnostics is a wholesale distributor of rapid point-of-care diagnostic tests and select pharmaceutical products for healthcare facilities. Its portfolio spans COVID-19, influenza A/B, RSV, Strep A, mononucleosis, multi-panel drug, pregnancy, and blood (A1c, cholesterol, lipid, glucose) tests, alongside Naloxone HCl nasal spray. The company serves pharmacies, hospitals, urgent cares, complex laboratories, senior housing, government entities, and businesses through an NABP-accredited, CLIA-certified distribution operation with an online ordering portal.
Is DB DIAGNOSTICS a public or private company?
DB DIAGNOSTICS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DB DIAGNOSTICS founded?
DB DIAGNOSTICS was founded in 2020. It employs 1 to 10 people.
Where is DB DIAGNOSTICS based?
DB DIAGNOSTICS is headquartered in Charlotte, United States, in the North America region.
How does DB DIAGNOSTICS make money?
Two revenue lines are on record. Diagnostic Test Sales are the primary driver. The others are pharmaceutical Supplies.
Who are DB DIAGNOSTICS's main competitors?
Broad incumbents on record are McKesson Corporation, Owens & Minor, Medline Industries, Cardinal Health, Henry Schein and Thermo Fisher Scientific. Direct peers are BTNX Inc. and QuidelOrtho. iHealth Labs is listed as an others. Wondfo USA is listed as an emerging player.
Does DB DIAGNOSTICS have an API?
No public API is recorded for DB DIAGNOSTICS.
What industry is DB DIAGNOSTICS in?
DB DIAGNOSTICS's product category is Diagnostic Supplies Distribution. Its primary akta.pro industry code is HLAFAKAO, Point-of-Care & Rapid Diagnostic Testing Centers (non-lab, non-imaging), with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 621511 and its SIC code is 5047.